|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 47/26 | (2006.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61K 31/485 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K 16/24 | (2006.01) |
| (11) | Number of the document | 3409269 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18174400.4 |
| Date of filing the European patent application | 2011-01-07 | |
| (97) | Date of publication of the European application | 2018-12-05 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-12 |
| (46) | Date of publication of the claims translation | 2020-10-12 |
| (30) | Number | Date | Country code |
| 29322710 P | 2010-01-08 | US |
| (72) |
DIX, Daniel, B, US
GRAHAM, Kenneth, S., US
KAMEN, Douglas, E., US
WALSH, Scott, M., US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Stabilizuotos kompozicijos, savo sudėtyje turinčios antikūnus prieš interleukino-6 receptorių (IL-6R) |
| STABILIZED FORMULATIONS CONTAINING ANTI-INTERLEUKIN-6 RECEPTOR (IL-6R) ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2024-12-18 | 15 | 289.00 EUR |
| 2026-01-07 |